Agios Pharmaceuticals, Inc. (AGIO)

Agios Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 14, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	2,004	1,587	1,874	1,245	1,543	1,785
Market Cap Growth	-5.81%	-15.30%	50.56%	-19.32%	-13.57%	-40.52%
Enterprise Value	1,070	375	274	448	607	488
Last Close Price	33.56	27.22	32.86	22.27	28.08	32.87

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 14, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	-	-	2.78	-	-	1.11
Forward PE	-	7.84	7.84	-	-	-
PS Ratio	20.37	29.38	51.35	46.40	108.35	-
PB Ratio	1.95	1.33	1.22	1.54	1.40	1.38
P/TBV Ratio	1.95	1.33	1.22	1.54	1.40	1.38

EV Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 14, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
EV/Sales Ratio	10.88	6.93	7.51	16.70	42.61	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 14, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Debt / Equity Ratio	0.03	0.03	0.04	0.09	0.08	0.08
Net Debt / Equity Ratio	-0.91	-0.94	-0.96	-0.90	-0.92	-0.92
Net Debt / EBITDA Ratio	2.06	2.41	3.51	1.91	2.66	3.22
Net Debt / FCF Ratio	2.56	2.98	3.77	2.47	3.22	2.88
Asset Turnover	0.08	0.04	0.03	0.03	0.01	-
Inventory Turnover	11.96	11.43	13.08	21.65	-	-
Quick Ratio	9.14	10.53	11.06	11.49	12.54	17.17
Current Ratio	10.22	11.46	11.90	12.27	13.30	17.79
Return on Equity (ROE)	-34.34%	-30.20%	57.29%	-36.83%	-19.38%	-42.15%
Return on Assets (ROA)	-22.24%	-19.93%	-20.47%	-22.49%	-18.17%	-20.65%
Return on Invested Capital (ROIC)	-108.33%	-87.18%	-98.60%	-153.69%	-100.74%	-251.59%
Return on Capital Employed (ROCE)	-44.20%	-38.90%	-26.90%	-45.00%	-33.10%	-27.50%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 14, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Earnings Yield	-20.53%	-26.00%	35.95%	-28.29%	-15.02%	89.89%
FCF Yield	-18.23%	-23.77%	-20.89%	-23.87%	-20.38%	-23.14%
Buyback Yield / Dilution	-0.43%	-0.14%	-4.02%	-1.57%	9.36%	12.39%

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Jul 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 14, 2026

Data Sources Report a data error